Individual Genome Sequencing
Illumina was founded in 1998 with the vision of becoming the world’s leading provider of integrated tools and services that advance the understanding of genetics and health. Today, our platforms and assays are helping make studies possible that were not even imaginable just a few years ago. Whether enabling researchers to discover the genetic underpinnings of disease risk, physicians to guide targeted treatment, or individuals to better understand their genome, our technologies provide the most accurate, comprehensive report of what's present in our DNA.
Your genome. Your story.
For years, researchers have been able to increase the pace of their genetic research and advance their understanding of DNA using Illumina's leading-edge technologies. Now, through your doctor, you can take advantage of this same world-class technology with the Individual Genome Sequencing (IGS) service.